PMDA drug package insert
オメガ−3脂肪酸エチル粒状カプセル2g「MJT」
PMDA Prescription drug · 森下仁丹株式会社 · package insert Nov 13, 2024
Key facts
| Brand names | オメガ−3脂肪酸エチル粒状カプセル2g「MJT」 |
|---|---|
| Nonproprietary names | オメガ－３脂肪酸エチル |
| Companies | 製造販売元／森下仁丹株式会社, 販売元／共創未来ファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | EPA・DHA製剤 |
| Therapeutic category codes | 872189 |
| YJ codes | 2189019M1039 |
| Approval numbers | 30400AMX00113000 |
| Package insert edition | 第2版 |
| Package insert date | Nov 13, 2024 |
| PMDA document key | 790021_2189019M1039_1 |
| PMDA company code | 790021 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: